Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Lentz

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Opinion in Hematology|October 17, 1998
Mechanisms of thrombosis in hyperhomocysteinemiaS R Lentz
Clinical Pharmacology and Therapeutics|May 15, 2016
Genetic testing to guide warfarin dosing: Impact of direct oral anticoagulantsS R Lentz
Journal of Thrombosis and Haemostasis : JTH|August 17, 2005
Mechanisms of homocysteine-induced atherothrombosisS R Lentz
Life Sciences|January 1, 1997
Homocysteine and vascular dysfunctionS R Lentz
Arteriosclerosis, Thrombosis, and Vascular Biology|September 15, 2001
Does homocysteine promote atherosclerosis?S R Lentz
The Journal of Clinical Investigation|December 1, 1991
Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteineS R Lentz, J E Sadler
Journal of Thrombosis and Haemostasis : JTH|July 9, 2018
Targeting platelet EPCR for better therapeutic factor VIIa activityS X Gu, S R Lentz
The New England Journal of Medicine|January 10, 2002
Endothelial protein C activation in meningococcal sepsisW W Piette, S R Lentz
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
The benefits of excess EPCRT J Raife, S R Lentz
Blood|February 1, 1993
Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulumS R Lentz, J E Sadler
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Opinion in Hematology|October 17, 1998
Mechanisms of thrombosis in hyperhomocysteinemiaS R Lentz
Clinical Pharmacology and Therapeutics|May 15, 2016
Genetic testing to guide warfarin dosing: Impact of direct oral anticoagulantsS R Lentz
Journal of Thrombosis and Haemostasis : JTH|August 17, 2005
Mechanisms of homocysteine-induced atherothrombosisS R Lentz
Life Sciences|January 1, 1997
Homocysteine and vascular dysfunctionS R Lentz
Arteriosclerosis, Thrombosis, and Vascular Biology|September 15, 2001
Does homocysteine promote atherosclerosis?S R Lentz
The Journal of Clinical Investigation|December 1, 1991
Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteineS R Lentz, J E Sadler
Journal of Thrombosis and Haemostasis : JTH|July 9, 2018
Targeting platelet EPCR for better therapeutic factor VIIa activityS X Gu, S R Lentz
The New England Journal of Medicine|January 10, 2002
Endothelial protein C activation in meningococcal sepsisW W Piette, S R Lentz
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
The benefits of excess EPCRT J Raife, S R Lentz
Blood|February 1, 1993
Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulumS R Lentz, J E Sadler
Pageof 7